Media Releases

A large trial published in the New England Journal of Medicine is adding to the debate for patients who have had a kind of brain bleeding called aneurysmal subarachnoid haemorrhage (aSAH). Although the randomised controlled trial found no major difference in clinical outcomes between a restrictive compared to a liberal transfusion strategy in critically ill patients following an aSAH, the authors emphasise the potential value of integrating these results with other research to provide a deeper understanding.

Experts are warning Australians not to be conned by dodgy alcohol marketing this festive season, as new research released today by The George Institute for Global Health reveals consumers are up to three times more likely to think alcoholic drinks with sugar- or carb-related claims are ‘healthy’ compared to those without.1 The effect was strongest in younger drinkers (18-24), potentially offsetting recent gains in reducing harmful levels of drinking in this age group.

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes. Findings were published today in The Lancet Diabetes & Endocrinology.